au.\*:("OLIVER, R. T. D")
Results 1 to 25 of 117
Selection :
Surveillance as a possible option for management of metastatic renal cell carcinomaOLIVER, R. T. D.Seminars in urology. 1989, Vol 7, Num 3, pp 149-152, issn 0730-9147Article
Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now?OLIVER, R. T. D.British journal of cancer. 1998, Vol 77, Num 8, pp 1318-1320, issn 0007-0920Article
New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancerOLIVER, R. T. D.European journal of cancer : (1990). 1991, Vol 27, Num 9, pp 1168-1172Article
Factors contributing to delay in diagnosis of testicular tumoursOLIVER, R. T. D.British medical journal (1857). 1985, Vol 290, Num 6465, issn 0007-1447, 356Article
Testosterone : Its role in development of prostate cancer and potential risk from use as hormone replacement therapySLATER, Sarah; OLIVER, R. T. D.Drugs & aging. 2000, Vol 17, Num 6, pp 431-439, issn 1170-229XArticle
Advanced testicular cancer presenting with phlegmasia cerulea dolensMULATERO, C; BROGAN, G; OLIVER, R. T. D et al.Postgraduate medical journal. 2000, Vol 76, Num 894, pp 234-236, issn 0032-5473Article
Alternatives to radiotherapy in the management of seminomaOLIVER, R. T. D; LORE, S; ONG, J et al.British journal of urology (Print). 1990, Vol 65, Num 1, pp 61-67, issn 0007-1331Conference Paper
Recent progress in cytokine therapy for renal cell cancer : A case for the European Organization for Research and Treatment of Cancer adjuvant cytokine trial in patients with poor-risk renal cell cancer after maximum debulking surgeryRAVI, R; OLIVER, R. T. D.British journal of urology (Print). 1999, Vol 83, Num 3, pp 219-221, issn 0007-1331Article
A physician's perspectiveOLIVER, R. T. D.Cancer surveys. 1995, Vol 23, pp 309-310, issn 0261-2429Conference Paper
Intermittent endocrine therapy and its potential for chemoprevention of prostate cancerOLIVER, R. T. D; GALLAGHER, C. J. G.Cancer surveys. 1995, Vol 23, pp 191-207, issn 0261-2429Conference Paper
Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancerNOURI, A. M. E; HYDE, R; OLIVER, R. T. D et al.Cancer immunology and immunotherapy. 1994, Vol 39, Num 1, pp 68-70, issn 0340-7004Article
Castration-induced lymphocytosis in prostate cancer : possible evidence for gonad/thymus endocrine interaction in manOLIVER, R. T. D; JOSEPH, J. V; GALLAGHER, C. J et al.Urologia Internationalis. 1995, Vol 54, Num 4, pp 226-229, issn 0042-1138Article
Hurricane growth of malignant trophoblastic teratomaRAJA, M. A; OLIVER, R. T. D; BLOMLEY, M et al.Postgraduate medical journal. 1993, Vol 69, Num 812, pp 472-473, issn 0032-5473Article
Nephrectomy combined with perioperative alpha-interferon in the treatment of advanced local and minimally metastatic renal cell cancerCOCKRELL, O. C; OLIVER, R. T. D; NETHERSALL, A et al.Urologia Internationalis. 1991, Vol 46, Num 1, pp 46-49, issn 0042-1138, 4 p.Article
Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosisMURUGAESU, N; POWLES, T; BESTWICK, J et al.Osteoporosis international. 2009, Vol 20, Num 9, pp 1627-1630, issn 0937-941X, 4 p.Article
Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. DiscussionLOOIJENGA, L. H. J; GILLIS, A. J. M; STOOP, H et al.International journal of andrology (Print). 2007, Vol 30, Num 4, pp 304-315, issn 0105-6263, 12 p.Conference Paper
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancerGOONEWARDENE, T. I; BOZCUK, H; OLIVER, R. T. D et al.Urologia Internationalis. 2001, Vol 67, Num 4, pp 293-297, issn 0042-1138Article
CT assessment of tumour response to treatment : comparison of linear, cross-sectional and volumetric measures of tumour sizeSOHAIB, S. A; TURNER, B; HANSON, J. A et al.British journal of radiology. 2000, Vol 73, Num NOV, pp 1178-1184, issn 0007-1285Article
Computed tomography 21 days after chemotherapy, three-dimensional estimates of metastatic volume and the need for surgery in patients with germ cell cancerBOZCUK, H. S; RAVI, R; TURNER, B et al.BJU international (Papier). 2000, Vol 86, Num 6, pp 707-713, issn 1464-4096Article
Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancerBAITHUN, S; DARUWALA, P; OLIVER, R. T. D et al.Cancer surveys. 1998, Vol 31, pp 17-27, issn 0261-2429Article
Malignancy associated papillomaviruses and morphology of human bladder cancerOLIVER, R. T. D; BREUER, J; NOURI, A. M. E et al.Cancer surveys. 1998, Vol 31, pp 29-47, issn 0261-2429Article
Gonadal function in men with testicular cancer : Biological and clinical aspects. DiscussionPETERSEN, P. M; SKAKKEBAEK, N. E; GIWERCMAN, A et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1998, Vol 106, Num 1, pp 24-36, issn 0903-4641Conference Paper
Oct-4 : more than just a POUerful marker of the mammalian germline? DiscussionBREHM, A; OVITT, C. E; SCHÖLER, H. R et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1998, Vol 106, Num 1, pp 114-126, issn 0903-4641Conference Paper
Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancerJEYARAJAH, A. R; GALLAGHER, C. J; BLAKE, P. R et al.Gynecologic oncology (Print). 1996, Vol 63, Num 1, pp 47-52, issn 0090-8258Article
Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994OLIVER, R. T. D; ONG, J; BLANDY, J. P et al.British journal of urology (Print). 1996, Vol 78, Num 1, pp 119-124, issn 0007-1331Conference Paper